Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2A9H

NMR structural studies of a potassium channel / charybdotoxin complex

Summary for 2A9H
Entry DOI10.2210/pdb2a9h/pdb
NMR InformationBMRB: 6728
DescriptorVoltage-gated potassium channel, charybdotoxin (2 entities in total)
Functional Keywordspotassium channel, kcsa, membrane protein, metal transport
Biological sourceStreptomyces lividans
Total number of polymer chains5
Total formula weight71179.89
Authors
Yu, L.,Sun, C.,Song, D.,Shen, J.,Xu, N.,Gunasekera, A.,Hajduk, P.J.,Olejniczak, E.T. (deposition date: 2005-07-11, release date: 2006-01-10, Last modification date: 2024-11-20)
Primary citationYu, L.,Sun, C.,Song, D.,Shen, J.,Xu, N.,Gunasekera, A.,Hajduk, P.J.,Olejniczak, E.T.
Nuclear magnetic resonance structural studies of a potassium channel-charybdotoxin complex.
Biochemistry, 44:15834-15841, 2005
Cited by
PubMed Abstract: Ion channels play critical roles in signaling processes and are attractive targets for treating various diseases. Here we describe an NMR-based strategy for structural analyses of potassium channel-ligand complexes using KcsA (residues 1-132, with six mutations to impart toxin binding and to mimic the eukaryotic hERG channel). Using this approach, we determined the solution structure of KcsA in complex with the high-affinity peptide antagonist charybdotoxin. The structural data reveal how charybdotoxin binds to the closed form of KcsA and makes specific contacts with the extracellular surface of the ion channel, resulting in pore blockage. This represents the first direct structural information about an ion channel complexed to a peptide antagonist and provides an experimental framework for understanding and interpreting earlier mutational analyses. The strategy presented here overcomes many of the limitations of conventional NMR approaches to helical membrane protein structure determination and can be applied in the study of the binding of druglike molecules to this important class of proteins.
PubMed: 16313186
DOI: 10.1021/bi051656d
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon